Why AffirmHealth Partners With Healthcare SystemsJul 30, 2018 9:09:00 AM by AffirmHealth posted in opioid prescribing compliance, Pain Guidelines, prescribing protocols, risk assessment
Michigan: Controlled Substance Legislation UPDATEJun 26, 2018 9:03:00 AM by Jody Lutz posted in PDMPs, Opioid Epidemic, chronic pain, Pain Management, Guidelines, Clinical Tools, prescriber compliance, opioid prescribing compliance, prescribing protocols, Medication Assisted Treatment Protocols, risk assessment, Treatment Agreements, Informed Consent, patient safety, Michigan, opioid legislation
In December of 2017, Michigan’s Lt. Governor Brian Calley signed a comprehensive 10-bill package to address Michigan’s opioid epidemic, substance abuse and drug diversion problems. The multi-faceted package addresses various education initiatives from school aged children to patient informed consent and also covers acute pain prescriptions, MAPS and a variety of other topics impacting the prescribing of controlled substances in Michigan.Read More
Are You Effectively Assessing Risk When Prescribing Opioids?Apr 3, 2018 5:04:00 AM by John Cole posted in Opioid Prescribing Guidelines, opioid prescribing, risk assessment
The staggering rate of prescription opioid misuse, abuse, and overdose has placed a heavy burden on prescribing clinicians and their practices. Federal and state regulators have responded by enacting extensive opioid prescribing guidelines. Across the board, these guidelines prioritize the importance of properly assessing a patient’s risk of misuse or abuse.Read More
The information presented on or through this website is made available solely for general information purposes and is not intended to substitute for professional, medical or legal advice. We do not warrant the accuracy, completeness, or usefulness of this information. Any reliance you place on such information is strictly at your own risk. We disclaim all liability and responsibility arising from any reliance placed on such materials.